50.82
Schlusskurs vom Vortag:
$50.31
Offen:
$49.875
24-Stunden-Volumen:
150.11K
Relative Volume:
0.14
Marktkapitalisierung:
$2.63B
Einnahmen:
$412.82M
Nettoeinkommen (Verlust:
$-8.19M
KGV:
-329.79
EPS:
-0.1541
Netto-Cashflow:
$64.17M
1W Leistung:
+2.32%
1M Leistung:
+8.70%
6M Leistung:
+186.08%
1J Leistung:
+277.32%
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CDNA
Caredx Inc
|
50.75 | 2.60B | 412.82M | -8.19M | 64.17M | -0.1541 |
|
TMO
Thermo Fisher Scientific Inc
|
602.90 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
202.98 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
324.74 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
IQV
Iqvia Holdings Inc
|
256.49 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
IDXX
Idexx Laboratories Inc
|
518.88 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
Are Medical Stocks Lagging CareDx (CDNA) This Year? - Yahoo Finance
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup - ChartMill
CDNA Initiates Coverage by Canaccord Genuity -- Price Target Set at $65 - GuruFocus
Canaccord Genuity Initiates Coverage of CareDx, BillionToOne With Buy Ratings - GenomeWeb
Canaccord initiates CareDx stock coverage with buy rating on testing By Investing.com - Investing.com South Africa
Canaccord Genuity Initiates CareDx at Buy With $65 Price Target - marketscreener.com
Canaccord initiates CareDx stock coverage with buy rating on testing - Investing.com India
CareDx (CDNA) is a Great Momentum Stock: Should You Buy? - Eastern Progress
Caredx Inc stock hits 52-week high at 49.77 USD By Investing.com - Investing.com Canada
Caredx Inc stock hits 52-week high at 49.77 USD - Investing.com
Is CareDx’s AI and EHR Push Reshaping Its Role In Transplant Care Infrastructure (CDNA)? - Sahm
Zacks Industry Outlook CareDx, BrightSpring and PACS - Yahoo Finance
CareDx (CDNA) Shares Jumped, So What Is Driving Attention Now? - Yahoo Finance
Is CareDx (CDNA) Fully Priced After Its Strong Three Year Run? - Yahoo Finance
Is CareDx Inc (CDNA) Overvalued After 3.5% Rally? GF Value Says - GuruFocus
CareDx Inc (1K9) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
CareDx Inc (1K9) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
CareDx Inc (1K9) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Ron Baron Trims CareDx Inc (CDNA) Stake -- Shares Trade 86% Above GF Value - GuruFocus
CareDx (CDNA) Rallies On Growth Optimism, Is It Still 10% Undervalued? - Sahm
Price to book forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
CareDx (NASDAQ:CDNA) Passes Minervini Trend Template and High Growth Momentum Screen - ChartMill
CareDx (CDNA) Q2 2026 Results: EPS Exceeds Its Estimate in the Latest Reading; Stock Move: The Stock Loses 0.43% in the Current UpdateAnalyst Consensus Shift - vinanet.vn
Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar - Yahoo Finance
CareDx Market Sentiment - Benzinga France
Price to book forward of CareDx, Inc. – DUS:1K9 - TradingView
CareDx (NASDAQ: CDNA) insider lines up $423K stock sale - Stock Titan
CareDx Deadline Alert - TMX Newsfile
CareDx Inc (CDNA) Shares Fall 4.3% -- What GF Score of 67 Tells Investors - GuruFocus
CareDx (CDNA) insider Peter Maag files to sell 7,000 shares after large prior sales - Stock Titan
Baron group trims CareDx (CDNA) stake to 3.75% in latest 13G/A - Stock Titan
CareDx Inc Earnings Call Highlights Growth And Risks - TipRanks
CDNA (CDNA) insider Peter Maag discloses 7,000-share planned sale and recent trades - Stock Titan
Does CareDx’s Profit Jump And Higher 2026 Outlook Change The Bull Case For CDNA? - simplywall.st
CareDx (CDNA) insider Peter Maag files to sell 7,000 NASDAQ-listed shares - Stock Titan
Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA) - Yahoo Finance
CareDx Stock Is Up 300% Over the Past Year. Here’s How Much Upside Is Left. - webull.com
CDNA (CDNA) insider Peter Maag files Form 144 for 6,902-share stock sale - Stock Titan
Arthur Torres (CDNA) files Form 144 to sell 4,200 shares of common stock - Stock Titan
This Insider Has Just Sold Shares In CareDx - webull.com
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - webull.com
Have Insiders Sold CareDx Shares Recently? - Moomoo
Zacks Research Upgrades CareDx (NASDAQ:CDNA) to Strong-Buy - MarketBeat
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Finviz
CareDx (CDNA): Neil Gagnon and Gagnon entities report 4.4% ownership stake - Stock Titan
CareDx (NASDAQ: CDNA) insider Peter Maag plans 27,332-share stock sale after option exercise - Stock Titan
CareDx Inc (CDNA) Stock News Today - TradingKey
CareDx Inc (CDNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
State Street (CDNA holder) discloses 2.47M CareDx shares under shared control - Stock Titan
CareDx (NASDAQ:CDNA) Is Posting Healthy Earnings, But It Is Not All Good News - Moomoo
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):